Likewise, a bispecific aptamer (MRP1-CD28) was used to guide CD28 agonistic aptamers to cancer stem cells expressing multidrug resistance-associated protein 1 (MRP1, also called ABCC1), which is ubiquitously expressed in aggressive tumors [165]. Here, CD28 is linked to cancer.